News

Genentech’s ICON7 study is a multicenter, randomised, open-label, Phase III study in 1,528 women with previously untreated epithelial ovarian, primary peritoneal or fallopian tube carcinoma. The primary endpoint

In the study, Votrient has been shown to effectively slow down the progression of advanced RCC, whilst maintaining quality of life (QoL) as shown by the mean change

Effexor XR (venlafaxine HCl) extended-release capsules are indicated for the treatment of depression, generalised anxiety disorder (GAD), social anxiety disorder (SAD), and panic disorder (PD) with or without

Mr Cao is expected to continue his role as the chairman of the company’s board. Earlier, in April 2008, Mr Jin joined Laiyang Jiangbo Pharmaceuticals, the wholly owned

As per the terms of the amendment, GSK is expected to take up the responsibility for developing Ofatumumab in autoimmune indications while continuing to jointly develop Ofatumumab with

PharmaPros said that eClinical OnDemand offers clients as an option to incorporate other data sources such as central laboratories and imaging centers, as well as 3rd party EDC,

ClinTec said that its US operations are into servicing international companies on projects by partnering with US CROs that had no or limited international presence. ClinTec claimed that

Butrans is available in three strengths 5, 10, and 20mcg/hour, each single patch is intended to be worn for seven days. Butrans Transdermal System’s active ingredient is buprenorphine,

According to hematopoietic stem cells (HSC) model, the two progenitor cell types, T and B cells, lose the potential to develop into non-lymphocytes (myeloid cells) once they pass